Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Any ideas what happens next?
View:
Post by Oilminerdeluxe on Sep 11, 2021 10:40am

Any ideas what happens next?

It will be tough to wait for the next quarterly update for info of any kind. Any chance we get a virus update or anything else of worth before that?
Comment by socksnblonds642 on Sep 11, 2021 11:45am
Don't think so. We wait for trial results. Right now it's strictly a cancer company. Covid vaccine might be very real but for now it's only a pipe dream. I've been down this small biotech road re covid. The price spiked a bit during animal trials. They did the dance with "incorrect dosage"  Then the damn rats died. Whoops! Until Theralse has human vaccine trials a ...more  
Comment by patience69 on Sep 11, 2021 1:16pm
IMO it almost seems like something really big was brewing then fell apart. Major delay for newsletter still does not seem to have a real reason? Major deals can take a long time to make. As we treat more & get better results & the first 12 fade out then our value only increases. That's also something for our suitors to keep in mind. All iMO
Comment by MuskieMan50 on Sep 11, 2021 10:19pm
I wish I knew what was coming next but I feel something is ongoing.I get that the newsletter is sporatic but this time we were two thirds into next quarter before we got it. Management said they were waiting on some information and I doubt that was the exit of Shawn.Also there is no indication of looking for a new CEO,could that be coming with some part of a deal?I know everyone here wants TLT to ...more  
Comment by chry200030 on Sep 11, 2021 10:32pm
Buyout at some point... just be patient.. maybe next year, maybe year after.. It will be worth the wait.! 
Comment by Gooseybear on Sep 12, 2021 7:40am
I hope so. Continuing to add more shares. 
Comment by MuskieMan50 on Sep 20, 2021 8:53pm
Patience69, I think you may have been on to something.When you also consider the insider purchases,some by insiders that have never stepped up before back in May.The RW stopped his regular purchasing only to buy again in Sept.Other things like SS leaving and no indication of looking for new CEO. Massive delay of quarterly and now total silence.Maybe some sort of negotiations were in play. Will ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250